Drugs / Px-102
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01998672 Comparator | Feb → Oct 2012 | — | Phenex Pharmaceuticals AG | Completed | No outcome recorded |
| Phase 1 | NCT01998659 Comparator | Sep → Dec 2011 | — | Phenex Pharmaceuticals AG | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Px-102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01998659 ↗ |
| Action | Activate | “Bile acid receptor FXR agonist” CHEMBL3822773 ↗1“FXR agonist Px-102” NCT01998659 ↗ |
| Modality | Small molecule | — CHEMBL3822773 ↗ |
| Route | Oral | “single oral dosing” NCT01998659 ↗ |
| Target | NR1H4 | “Bile acid receptor FXR agonist” CHEMBL3822773 ↗ |